This review explores decision-making challenges in locally advanced rectal cancer, highlighting patient preferences and future strategies.
Decision-making in oncology is uniquely challenging, requiring patients to interpret complex information, weigh uncertain outcomes, and balance survival with quality-of-life considerations. In locally advanced rectal cancer, evolving treatment options such as total neoadjuvant therapy, selective radiation, and nonoperative management via watch-and-wait have made decision-making increasingly nuanced. These choices are preference-sensitive, meaning the optimal approach depends not on a single clinical standard but on the patient's values, goals, and risk tolerance. This review explores how patients navigate key decision points in locally advanced rectal cancer management. We examine individual-level factors that shape decision-making and describe how patients process trade-offs between oncologic risk and functional outcomes. The review also discusses models that support patient decision-making and outlines future directions for research, clinical training, and the development of tools to better understand and meet patients' decisional needs.
No takes yet. Share an insight, caveat, or question.
Gaetani et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: